Valuation: Baxter International Inc.

Market Cap 13.63B 12.28B 11.35B 10.26B 19.41B 1,278B 19.89B 136B 54.2B 684B 51.14B 50.05B 2,178B P/E 2026 *
21.3x
P/E 2027 * 19.2x
Enterprise Value 20.46B 18.44B 17.03B 15.4B 29.13B 1,919B 29.85B 204B 81.37B 1,028B 76.77B 75.14B 3,270B EV / Sales 2026 *
1.74x
EV / Sales 2027 * 1.65x
Free-Float
75.44%
Yield 2026 *
0.15%
Yield 2027 * 0.15%
1 day-0.30%
1 week-0.60%
Current month+14.52%
1 month+8.17%
3 months-4.60%
6 months+50.26%
Current year+37.83%
1 week 24.76
Extreme 24.7615
26.71
1 month 22.5
Extreme 22.495
27.08
Current year 15.73
Extreme 15.73
30
1 year 15.73
Extreme 15.73
30
3 years 15.73
Extreme 15.73
44
5 years 15.73
Extreme 15.73
89.7
10 years 15.73
Extreme 15.73
95.19
Manager TitleAgeSince
Chief Executive Officer 49 01/08/2025
Chief Tech/Sci/R&D Officer 57 01/01/2024
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 66 18/02/2019
Director/Board Member 65 01/01/2019
Director/Board Member 69 15/02/2021
Date Insider Type Main position Quantity % Market Cap. Importance
01/10/26 Other

EVP and CFO

0 0.0000% -
02/09/26 Tax

President, Front Line Care

-2,098 0.0004%
02/09/26 Tax

Chief Executive Officer

-54,276 0.0105%
Change 5-day change 1-year change 3-year change Capi.($)
-0.30%-0.60%+44.33%-19.74% 13.63B
-1.06%-5.38%-13.94%+16.30% 189B
+0.02%-3.19%+6.51%+43.76% 124B
-1.70%-6.14%-12.35%+16.51% 121B
-0.44%-5.31%-43.33%+2.82% 93.09B
+0.34%-1.16%-4.16%+77.09% 66.77B
+0.90%+2.55%+13.49%-8.58% 58.43B
+0.85%+0.58%-1.39%+63.88% 55.35B
+0.96%+0.06%-1.73%+56.33% 49.49B
+1.83%-3.28%-5.21%-7.47% 34.53B
Average +0.14%-2.15%-1.78%+24.09% 81B
Weighted average by Cap. -0.27%-3.06%-8.17%+26.34%

Financials

2026 *2027 *
Net sales 11.72B 10.57B 9.76B 8.83B 16.7B 1,100B 17.11B 117B 46.63B 589B 44B 43.07B 1,874B 11.96B 10.78B 9.96B 9B 17.03B 1,122B 17.45B 119B 47.57B 601B 44.89B 43.93B 1,912B
Net income 621M 560M 517M 467M 884M 58.24B 906M 6.2B 2.47B 31.19B 2.33B 2.28B 99.25B 601M 542M 501M 453M 856M 56.4B 878M 6B 2.39B 30.21B 2.26B 2.21B 96.12B
Net Debt 6.83B 6.16B 5.69B 5.14B 9.73B 641B 9.97B 68.16B 27.17B 343B 25.63B 25.09B 1,092B 6.14B 5.54B 5.12B 4.62B 8.75B 576B 8.97B 61.31B 24.44B 309B 23.06B 22.57B 982B
Projected Income Statement - Annual - Baxter International Inc.
Logo Baxter International Inc.
Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - systems for delivering medications and intravenous therapy (47.1%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, and biosurgery (fibrin sealant, surgical gel, hemostatic pads, etc.), etc.; - medical equipment (27.3%): smart bed systems, patient monitoring systems, diagnostic equipment, respiratory health devices, and advanced operating room equipment, etc.; - pharmaceutical products and services (22.2%): injectable medications, inhaled anesthetics, and drug compounding services; - other (3.4 %). The United States account for 54.4% of net sales.
Employees
37,500
Date Price Change Volume
11/11/26 $26.34 -0.30% 3,826,031
10/11/26 $26.42 +0.04% 3,830,324
09/11/26 $26.41 +2.40% 4,538,672
06/11/26 $25.79 +0.55% 6,195,174
05/11/26 $25.65 -3.21% 10,103,099
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Baxter International Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
15
Last Close Price
26.34USD
Average target price
27.25USD
Spread / Average Target
+3.45%